Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat

13 Nov 2020

Abstract excerpt

experiments and consistent with previous virus cell entry assays. Our TMPRSS2-drug structures are made public to guide the design of more potent and specific inhibitors.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Pharmacological Receptor Mechanisms and Effects
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35382133
DOI: 10.1039/d0sc05064d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostatPMID 35382133Read ↗

Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human CellsSemantic proximity Read ↗

Homology Modeling and Docking Studies of TMPRSS2 with Experimentally Known Inhibitors Camostat Mesylate, Nafamostat and Bromhexine Hydrochloride to Control SARS-Coronavirus-2Semantic proximity Read ↗

Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activationSemantic proximity Read ↗

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitorsSemantic proximity Read ↗

Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2Semantic proximity Read ↗

Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivoSemantic proximity Read ↗

Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cellsSemantic proximity Read ↗

Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 targetSemantic proximity Read ↗

[Originality of entry inhibitors].Semantic proximity Read ↗

TRPV1 antagonism occurs through diverse structural mechanismsSemantic proximity Read ↗

A pan-positive allosteric modulator that mediates sustainable GPCR activationSemantic proximity Read ↗

An Update on the Current State of SARS-CoV-2 Mac1 InhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.